A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion

• Status: Not yet recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This project is to explore the effect of adjuvant chemotherapy on total tumor survival time, progression-free survival time, and recurrence-free survival time in patients with pTanyN0M0 upper urinary urothelial carcinoma with lymphatic vascular invasion (LVI) through a prospective case-control study.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Qinghua Xia,Prof
• Treatments: Cisplatin; Gemcitabine

Criteria

Inclusion Criteria:

1. Aged 20-85 years;

2. ECOG score 0-1 points;

3. Patients with UTUC, undergoing radical nephrectomy, pathological staging For pTanyN0M0;

4. Patients voluntarily signed informed consent.

Exclusion Criteria:

1. Obvious cardiopulmonary dysfunction, serious diabetes and other chronic diseases;

2. Obvious chemotherapy contraindications;

3. Patients have a history of other organ malignancies;

4. Combined with tumors of other sites.